Andrew Boczkowski, assistant general counsel and pro bono committee chair at GSK.
The multinational pharmaceutical company GlaxoSmithKline saw its global pro bono program volunteers increase to 49 legal department members in 2019, a 77% increase from the prior year.
From its inception in 2005, the U.S. pro bono program started with around 10 volunteers, including co-founder Andrew Boczkowski, assistant general counsel and pro bono committee chair at GSK in Philadelphia. Twelve years later, the program decided to expand to its global offices in London, where the company is headquartered, and Singapore. But one obstacle stood in the way that thwarts many global corporate legal departments’ volunteer efforts: pro bono malpractice insurance.
